Literature DB >> 16222109

Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography.

Akihiko Shiraishi1, Yoshihisa Kurosaki, Tadayuki Maehara, Masaru Suzuki, Masafumi Kurosumi.   

Abstract

The purpose of this study is to evaluate the capability of breast MRI (magnetic resonance imaging) and mammography in determining tumor extent and the detectability of ductal carcinoma in situ (DCIS) in association with histopathological features. Thirty women with breast cancer underwent 3D dynamic MRI. Twelve women had pure DCIS and 18 women had DCIS with microinvasion. We analyzed the results of preoperative MRI and mammography with histopathologic results, retrospectively. The mean lesion size was 55.1 mm from the histopathologic results. Twenty-six lesions were detected through the MRI (a sensitivity of 86.7%). MRI depicted eight lesions without mammographically detected microcalcification. In seven cases, MRI showed tumor extent accurately compared with mammography, and the combined diagnosis improved the accuracy of evaluating tumor extent. MRI can complement mammography in guiding surgical treatment of DCIS by providing better assessment of the extent of the lesion.

Entities:  

Mesh:

Year:  2003        PMID: 16222109     DOI: 10.2463/mrms.2.159

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  8 in total

1.  Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ.

Authors:  Francesca Proulx; José A Correa; Romuald Ferré; Atilla Omeroglu; Ann Aldis; Sarkis Meterissian; Benoît Mesurolle
Journal:  Br J Radiol       Date:  2015-11-16       Impact factor: 3.039

2.  The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.

Authors:  Kaoru Itakura; Juan Lessing; Theadora Sakata; Amy Heinzerling; Eline Vriens; Dorota Wisner; Michael Alvarado; Laura Esserman; Cheryl Ewing; Nola Hylton; E Shelley Hwang
Journal:  Clin Breast Cancer       Date:  2011-03       Impact factor: 3.225

3.  DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?

Authors:  Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Maryellen Giger; Gillian M Newstead
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

4.  What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?

Authors:  F Sardanelli; L Bacigalupo; L Carbonaro; A Esseridou; G M Giuseppetti; P Panizza; V Lattanzio; A Del Maschio
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

Review 5.  The impact of sentinel lymph node biopsy and magnetic resonance imaging on important outcomes among patients with ductal carcinoma in situ.

Authors:  Todd M Tuttle; Tatyana Shamliyan; Beth A Virnig; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

6.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

Authors:  Siwa Chan; Jeon-Hor Chen; Garima Agrawal; Muqing Lin; Rita S Mehta; Philip M Carpenter; Orhan Nalcioglu; Min-Ying Su
Journal:  J Oncol       Date:  2010-09-21       Impact factor: 4.375

Review 7.  Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions.

Authors:  A C Schmitz; D Gianfelice; B L Daniel; W P Th M Mali; M A A J van den Bosch
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 7.034

8.  Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.

Authors:  Jeeyeon Lee; Jin Hyang Jung; Wan Wook Kim; Chan Sub Park; Ryu Kyung Lee; Hye Jung Kim; Won Hwa Kim; Ho Yong Park
Journal:  BMC Cancer       Date:  2020-09-29       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.